Main Article Content

Abstract

RÉSUMÉ
Objectif. Le but de ce travail était de décrire les aspects cliniques et anatomopathologiques des cancers gastriques à l’Hôpital Général de Yaoundé et au Centre Médical La Cathédrale de Yaoundé. Méthodologie. Il s’agit d’une étude transversale descriptive avec collecte rétrospective des données s’étalant sur une période de 5 ans allant du 1er Janvier 2016 au 31 Décembre 2020. Étaient inclus tous les dossiers complets de patients atteints de cancer gastrique histologiquement confirmé. L’échantillonnage a été consécutif. Les variables étudiées étaient les données sociodémographiques, les signes fonctionnels, les signes cliniques, les antécédents, les données anatomopathologiques. L’analyse des données était réalisée grâce au logiciel SPSS 22.0. Résultats. Nous avons étudié 80 dossiers. Le sex-ratio était de 1,1 en faveur des femmes, soit un pourcentage de 51,80 % de femmes contre 48,80 % pour les hommes. L’âge moyen était de 52,13 ans. L’épigastralgie était le principal motif de consultation et était retrouvé dans 98,80% des cas. Les principaux antécédents notés étaient la prise abusive d’anti-inflammatoires non stéroïdiens (73,80%), la consommation d’épices et de boissons gazeuses (73,80 %), la gastrite chronique (72,50%), et l’ulcère gastrique (30%). Le corps de l’estomac (53,80% des cas) était le siège le plus atteint par le cancer. Le type histologique le plus retrouvé était l’adénocarcinome. Conclusion. Au cours du cancer gastrique à Yaoundé, le sexe féminin est légèrement plus touché. L’épigastralgie est le principal motif de consultation et l’adénocarcinome le type histologique le plus représenté. Un accent doit être mis sur la prévention de cette affection en renforçant la politique nationale de lutte contre le cancer gastrique.
ABSTRACT
Objectives. The aim of this study was to describe the clinical and histopathological features of gastric cancers at the Yaoundé General Hospital and at the Yaoundé Cathedral Medical Center. Patients and methods. This was a descriptive cross-sectional study with retrospective data collection covering a period of 5 years from January 1, 2016 to December 31, 2020. All complete files of patients with histologically confirmed gastric cancer were included. Sampling was consecutive. The variables studied were sociodemographic data, functional signs, clinical signs, history, histopathological data. Data analysis was performed using SPSS 22.0 software. Results. We studied 80 files. The sex ratio F/M was 1.1, or a 51.80% of women against 48.80% of men. The average age was 52.13 years. Epigastralgia was the main reason for consultation and was found in 98.80% of cases. The main past medical history findings noted were the excessive use of nonsteroidal anti-inflammatory drugs (73.80%), the consumption of spices and soft drinks (73.80%), chronic gastritis (72.50%), and the gastric ulcer (30%). The body of the stomach was the most commonly affected site (53.80% of cases). The most common histological type was adenocarcinoma. Conclusion. In our setting, women are slightly more commonly affected by gastric cancer. Epigastralgia is the main reason for consultation and adenocarcinoma is the most common histological type. Emphasis should be placed on the prevention of this condition by strengthening the national policy for the fight against gastric cancer.

Keywords

Cancer Stomach Clinical Pathological Anatomy and Cytology Cancer Estomac Clinique Anatomie et Cytologie Pathologiques

Article Details

How to Cite
Majoumo Grâce, Manghe Roméo, Djapa Christelle, Ndam Njitoyap Aantonin, Binyom Pierre René, Atangana Paul, & Sando Zacharie. (2022). Aspects Cliniques et Anatomopathologiques des Cancers Gastriques à Yaoundé de 2016 à 2020: Clinical and histopathological features of gastric cancers in Yaounde from 2016 to 2020. HEALTH SCIENCES AND DISEASE, 23(5). Retrieved from https://hsd-fmsb.org/index.php/hsd/article/view/3593

References

  1. Rawla P, Barsouk A. Epidemiology of gastric cancer: global trends, risk factors and prevention. Przeglad Gastroenterol. 2019;14:26‑38.
  2. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. mai 2021;71:209‑49.
  3. Xie Y, Shi L, He X, Luo Y. Gastrointestinal cancers in China, the USA, and Europe. Gastroenterol Rep. 2021;9:91‑104.
  4. Hamdi Y, Abdeljaoued-Tej I, Zatchi AA, Abdelhak S, Boubaker S, Brown JS, et al. Cancer in Africa: The Untold Story. Front Oncol. 2021;11:650117.
  5. Ouedraogo S, Ouedraogo S, Kambire JL, Zoungrana SL, Ouattara DZ, Bambara B, et al. Profil épidémiologique, clinique, histologique et thérapeutique des cancers digestifs primitifs dans les régions nord et est du Burkina Faso. Bull Cancer (Paris). 2018;105:1119‑25.
  6. Ntagirabiri R, Karayuba R, Ndayisaba G, Niyonkuru S, Marebo S, Maregwa G. Cancer de l’estomac à Bujumbura : bilan de 22 ans au centre hospitalo-universitaire de Kamenge. J Afr Hépato-Gastroentérologie. 2016;10:121‑4.
  7. Ankouane F, Kowo M, Nonga BN, Vouffo F, Nzoumé J-M, Njoya O, et al. Histological Types of Gastric Cancer and Helicobacter pylori Infection in Yaoundé. J Cancer Ther. 2015;06:701‑8.
  8. Yusefi AR, Bagheri Lankarani K, Bastani P, Radinmanesh M, Kavosi Z. Risk Factors for Gastric Cancer: A Systematic Review. Asian Pac J Cancer Prev APJCP. 2018;19:591‑603.
  9. Nagini S. Carcinoma of the stomach: A review of epidemiology, pathogenesis, molecular genetics and chemoprevention. World J Gastrointest Oncol. 2012;4:156.
  10. Bang GA, Savom EP, Oumarou BN, Ngamy CKM, Moto GB, Boukar YME, et al. Clinical epidemiology and mortality risk factors of gastric cancer in a sub-Saharan African setting: a retrospective analysis of 120 cases in Yaoundé (Cameroon). Pan Afr Med J. 2020;37:104.
  11. Yan S, Li B, Bai Z-Z, Wu J-Q, Xie D-W, Ma Y-C, et al. Clinical epidemiology of gastric cancer in Hehuang valley of China: a 10-year epidemiological study of gastric cancer. World J Gastroenterol. 14 août 2014;20:10486‑94.
  12. Tian Y, Wan H, Lin Y, Xie X, Li Z, Tan G. Androgen receptor may be responsible for gender disparity in gastric cancer. Med Hypotheses. mai 2013;80:672‑4.
  13. Zhang B, Du T, Zang M, Chang Q, Fan Z, Li J, et al. Androgen receptor promotes gastric cancer cell migration and invasion via AKT-phosphorylation dependent upregulation of matrix metalloproteinase 9. Oncotarget. 15 nov 2014;5:10584‑95.
  14. Agbor NE, Esemu SN, Ndip LM, Tanih NF, Smith SI, Ndip RN. Helicobacter pylori in patients with gastritis in West Cameroon: prevalence and risk factors for infection. BMC Res Notes. 2018;11:559.
  15. Aminde JA, Dedino GA, Ngwasiri CA, Ombaku KS, Mahop Makon CA, Aminde LN. Helicobacter pylori infection among patients presenting with dyspepsia at a primary care setting in Cameroon: seroprevalence, five-year trend and predictors. BMC Infect Dis. 2019;19:30.
  16. Fehim S, Bouhaous R, Diaf M, Drici AM, Khaled MB. Epidemiological profile of gastric cancer in the northwestern region of Algeria: about 116 cases. J Gastrointest Oncol. août 2017;8:659‑64.
  17. Fock KM. Review article: the epidemiology and prevention of gastric cancer. Aliment Pharmacol Ther. 2014;40:250‑60.
  18. Braga-Neto MB, Carneiro JG, de Castro Barbosa AM, Silva IS, Maia DC, Maciel FS, et al. Clinical characteristics of distal gastric cancer in young adults from Northeastern Brazil. BMC Cancer. déc 2018;18:131.
  19. Bindu S, Mazumder S, Bandyopadhyay U. Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective. Biochem Pharmacol. 2020;180:114147.
  20. Eusebi LH, Telese A, Marasco G, Bazzoli F, Zagari RM. Gastric cancer prevention strategies: A global perspective. J Gastroenterol Hepatol. sept 2020;35:1495‑502.
  21. Sitarz R, Skierucha M, Mielko J, Offerhaus J, Maciejewski R, Polkowski W. Gastric cancer: epidemiology, prevention, classification, and treatment. Cancer Manag Res. 2018;10:239‑48.
  22. El Hanafy E, El Nakeeb A, Ezzat H, Hamdy E, Atif E, Kandil T, et al. How does epidemiological and clinicopathological features affect survival after gastrectomy for gastric cancer patients-single Egyptian center experience. World J Gastrointest Surg. 2016;8:444‑51.
  23. Kingue S, Ngoe CN, Menanga AP, Jingi AM, Noubiap JJN, Fesuh B, et al. Prevalence and Risk Factors of Hypertension in Urban Areas of Cameroon: A Nationwide Population-Based Cross-Sectional Study. J Clin Hypertens. oct 2015;17:819‑24.
  24. Assaad Khalil SH, Megallaa MH, Rohoma KH, Ismael H, AbouSeif M, Kharboush I, et al. Prevalence of type 2 diabetes mellitus in a sample of the adult population of Alexandria, Egypt. Diabetes Res Clin Pract. oct 2018;144:63‑73.
  25. Diop B, Dia AA, Sow O, Thiam O, Konaté I, Dieng M, et al. Prise en Charge Chirurgicale des Tumeurs Gastriques à Dakar : à Propos de 36 Observations. Health Sci Dis. 2017;18:34‑8.
  26. Yatagai N, Ueyama H, Ikemura M, Uchida R, Utsunomiya H, Abe D, et al. Clinicopathological and Endoscopic Features of Raspberry-Shaped Gastric Cancer in Helicobacter pylori-Uninfected Patients. Digestion. 2021;102:41‑8.
  27. Strong VE. Progress in gastric cancer. Updat Surg. 2018;70:157‑9.
  28. Parkin DM, Hämmerl L, Ferlay J, Kantelhardt EJ. Cancer in Africa 2018: The role of infections. Int J Cancer. 2020;146:2089‑103.
  29. Koura M, Some RO, Ouattara DZ, Napon-Zongo PD, Konsegre V, Somda SK. Le cancer de l’estomac dans un pays d’Afrique subsaharienne: aspects épidémiologiques, anatomocliniques et endoscopiques à Bobo-Dioulasso (Burkina Faso). Sci Santé. 2019;42.
  30. Kim SJ, Choi CW. Common Locations of Gastric Cancer: Review of Research from the Endoscopic Submucosal Dissection Era. J Korean Med Sci. 2019;34:e231.
  31. Eom BW, Jung K-W, Won Y-J, Yang H, Kim Y-W. Trends in Gastric Cancer Incidence According to the Clinicopathological Characteristics in Korea, 1999-2014. Cancer Res Treat. oct 2018;50:1343‑50.
  32. Mellouki I, Laazar N, Benyachou B, Aqodad N, Ibrahimi A. [Epidemiology of gastric cancer: experience of a Moroccan hospital]. Pan Afr Med J. 2014;17:42.
  33. Lee HH. ASO Author Reflections: Borrmann Type as a Characteristic Phenotype of Advanced Gastric Cancer. Ann Surg Oncol. 2018;25:778‑9.
  34. Song X-H, Zhang W-H, Kai-Liu, Chen X-L, Zhao L-Y, Chen X-Z, et al. Prognostic impact of Borrmann classification on advanced gastric cancer: a retrospective cohort from a single institution in western China. World J Surg Oncol. déc 2020;18(1):204.
  35. Soreide K, Sandvik OM, Søreide JA, Giljaca V, Jureckova A, Bulusu VR. Global epidemiology of gastrointestinal stromal tumours (GIST): A systematic review of population-based cohort studies. Cancer Epidemiol. 2016;40:39‑46.